Triple-negative breast cancer (TNBC) constitutes a heterogeneous group of malignancies
that are often aggressive and associated with a poor prognosis. The development of new …

Triple Negative Breast Cancer, TNBC, a highly aggressive and metastatic type of breast
cancer, is characterized by loss of expression of the estrogen receptor (ER), progesterone …

Breast cancer is the most prevalent cancer in women around the world, having a sudden
spread nowadays because of the poor sedentary lifestyle of people. Comprising several …

Triple-negative breast cancer (TNBC) is considered one of the un-manageable types of
breast cancer, involving devoid of estrogen, progesterone, and human epidermal growth …

TNBC (Triple Negative Breast Cancer) is a subtype of breast cancer with an aggressive
phenotype which shows high metastatic capability and poor prognosis. Owing to its intrinsic …

Triple-negative breast cancer (TNBC) represents a very heterogeneous group of breast
diseases. Currently, the backbone of therapy for TNBC is mainly chemotherapy as there are …

Triple-negative breast cancer (TNBC) is one of the most heterogeneous and aggressive
breast cancer subtypes with a high risk of death on recurrence. To date, TNBC is very …

Triple negative breast cancer (TNBC) is a malignant breast cancer subtype that is prone to
progression, with high associated metastasis and five-year mortality rates and an overall …

Triple-negative breast cancer (TNBC) accounts for almost 15% of all diagnosed breast
cancers and often presents high rates of relapses and metastases, with generally poor …

Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …